Home › Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101
 

Keywords :   


Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101

2014-07-21 15:41:01| Logistics - Topix.net

This clinical trial is called STARTRK-1, which stands for A/B/C, and is a Phase I/IIa, multicenter, single-arm, open-label clinical trial of continuous daily dosing of oral RXDX-101 in adult patients with locally advanced or metastatic cancer confirmed to be positive for relevant molecular alterations.

Tags: iii global trial phase

Category:Transportation and Logistics

Latest from this category

All news
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Forecast Discussion Number 5
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Wind Speed Probabilities Number 5
06.10Hurricane Kirk Forecast Discussion Number 29
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Public Advisory Number 5
06.10Hurricane Kirk Wind Speed Probabilities Number 29
Transportation and Logistics »
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Forecast Discussion Number 5
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Wind Speed Probabilities Number 5
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Hurricane Kirk Forecast Discussion Number 29
06.10Hurricane Kirk Wind Speed Probabilities Number 29
More »